medigraphic.com
ISSN 2594-1518 (Electronic)
ISSN 1405-0099 (Print)

2013, Number S1

<< Back Next >>

Cir Gen 2013; 35 (S1)

Reflujo recurrente

Cervantes CJ

Language: Spanish
References: 14
Page: 4-5
PDF size: 38.30 Kb.


Text Extraction

No abstract


REFERENCES

  1. Islam M, Goutte M, Slaughter JC, et al. BMI and esophageal acid exposure in extraesophageal GERD: A non-linear relationship. Gastroenterology 2010; 138: S641-2.

  2. Vakil N, Van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20.

  3. Castell DO, Kahrilas PJ, Richter JE, Vakil NM, Johnson DA, Zuckerman S, et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 2002; 97: 575-583.

  4. Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005; 100: 283-289.

  5. Shay SS, Tutuian R, Sifrim D, et al. Twenty-four hour impedance and pH monitoring (24-hr Imp-pH) in the evaluation of GERD patients with persistent symptoms despite bid proton pump inhibitors (PPI): A Multicenter Study (abstract). Gastroenterology 2004; 126: A324.

  6. Fass R, Fennerty MB, Vakil N. Nonerosive reflux disease-current concepts and dilemmas. Am J Gastroenterol 2001; 96: 303-314.

  7. Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009; 58: 295-309.

  8. Fass R. Proton pump inhibitor failure -What are the therapeutic options? Am J Gastroenterol 2009; 104: S33-S38.

  9. Fenton P, Terry ML, Galloway KD, et al. Is there a role for laparoscopic fundoplication in patients with non-erosive reflux disease (NERD)? [Abstract]. Gastroenterology 2000; 118: A481.

  10. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-1402.

  11. Juul-Hansen P, Rydning A. On-demand requirements in patient with endoscopy-negative GERD: H2-blocker versus PPI. Aliment Pharmacol Ther 2009; 29: 207-212.

  12. Soper NJ, Dunnegan D. Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg 1999; 229: 669-677.

  13. Braghetto I. Indications of antireflux surgery. A clinical experience and review of the literature. Rev Med Chile 2010; 138: 605-611.

  14. Priego P, Lobo E. Causas de conversión en la cirugía laparoscópica de la enfermedad por reflujo gastroesofágico: análisis de nuestra experiencia. Rev Esp Enferm Dig (Madrid) 2008; 100: 263-267.




2020     |     www.medigraphic.com